Worldwide strategic alliance for non-chiral chromatography

Novasep and instrAction have entered into an alliance that will offer customers in the pharmaceutical industry a combination of instrAction?s proprietary API-selective stationary phases and Novasep?s purification capabilities and high performance chromatography technologies.

Novasep and instrAction have entered into an alliance that will offer customers in the pharmaceutical industry a combination of instrAction’s proprietary API-selective stationary phases and Novasep’s purification capabilities and high performance chromatography technologies. Together, the companies aim to develop and operate or supply optimized large-scale chromatography processes for purifying synthetic and semi-synthetic compounds.

“With the ever-increasing complexity of pharmaceutical compounds, traditional purification processes including crystallization, and even normal or reversed-phase chromatography, are often too expensive, and, worse, ineffective,” says René De Vaumas, executive vice president in charge of Novasep Synthesis’ business development.

“We believe that together, instrAction and Novasep will develop solutions that will provide great improvement in the purification of a number of pharmaceutical compounds,” said Dr Thomas Schwarz, CEO of instrAction GmbH. “Moreover, we believe that our joint approach with a single point of contact and streamlined project management will help reduce process development timelines.”

For more information on the companies visit their websites at www.novasep.com and www.instraction.com